Storm Therapeutics Funding: $126M Raised, Series C (2024)

Storm Therapeutics is based in Cambridge, United Kingdom. It has raised $126M in total funding. Latest round: Series C.

Storm Therapeutics funding overview

Storm Therapeutics is based in Cambridge, United Kingdom. Storm Therapeutics has raised $126M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Storm Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include M Ventures, Pfizer Ventures, Taiho Ventures. 3 distinct backers are named across the disclosed rounds.

Storm Therapeutics at a glance

Total raised
$126M
Latest round
Series C
Latest round date
January 2024
Headquarters
Cambridge, United Kingdom
Notable investors
M Ventures, Pfizer Ventures, Taiho Ventures

Frequently asked about Storm Therapeutics funding

How much has Storm Therapeutics raised?
Storm Therapeutics has raised $126M in total disclosed funding across the rounds on record.
Who has invested in Storm Therapeutics?
M Ventures, Pfizer Ventures, Taiho Ventures are named among the investors backing Storm Therapeutics.
What was the latest Storm Therapeutics funding round?
The most recent disclosed round is a Series C, announced in January 2024.
Where is Storm Therapeutics based?
Storm Therapeutics is based in Cambridge, United Kingdom.
When did Storm Therapeutics last raise?
The last disclosed Storm Therapeutics round closed in January 2024 at Series C.

Round data for Storm Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Companies related to Storm Therapeutics (36)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026